IL10 and myeloid sarcoma: Overall, our findings showed that mean levels of the studied cytokines in MS were comparative with the levels reported in other MS studies, where authors were interested in profiling cytokines in serum (and/ or CSF) [13], excepted the anti-inflammatory cytokine IL10 which was slightly lower in our study.